Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | HUM | Humana Common | 19.4K | Sep 30, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HUM | Restricted Stock Units | Award | $94.5K | +295 | +2.21% | $320.19 | 13.6K | Sep 30, 2024 | Humana Common | 295 | Direct | F3 | |
holding | HUM | Restricted Stock Units | 22.8K | Sep 30, 2024 | Humana Common | 22.8K | Direct | F1 | ||||||
holding | HUM | Restricted Stock Units | 2.19K | Sep 30, 2024 | Humana Common | 2.19K | Direct | F2 | ||||||
holding | HUM | Restricted Stock Units | 430 | Sep 30, 2024 | Humana Common | 430 | Direct | F4 |
Id | Content |
---|---|
F1 | Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). |
F2 | Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). |
F3 | Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. |
F4 | Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. 100% of the award is vesting on 12/31/2024. |